-
CDE Released the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Settings
2019-05-29
On May 29, 2019, NMPA Center for Drug Evaluation issued the Notice on the Issuance of the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Setting.
-
NMPA Issued the Announcement on Issues Concerning the Import of Reference Drugs for Clinical Research of Biosimilar Drugs
2019-05-28
NMPA issued the Announcement on Issues Pertaining to the One-off Import of Reference Drugs for Biologicals in Clinical Trials (Announcement No. 94 of 2018) on November 30, 2018.
-
NMPA Issued 3 Guidelines for Technical Review of the Registration of Synthetic Resin Teeth and Others
2019-05-22
NMPA organized the formulation of and published the three Guidelines on May 22, 2019.
-
SAMR Issued the Measures for the Administration of Imported Medicinal Materials
2019-05-17
To strengthen the administration and guarantee the quality of imported medicinal materials, on May 16, 2019, the State Administration for Market Regulation (SAMR) issued the revised Measures for the Administration of Imported Medicinal Materials (SAMR Order No. 9.
-
General Office of the State Council Issued the Opinions on Establishing a Team of Professionalized & Specialized Drug Inspectors
2019-07-19
Recently, the General Office of the State Council issued the Opinions on Establishing a Team of Professionalized & Specialized Drug Inspectors.
-
NMPA Issued the Announcement on Issues Concerning the Further Improvement of Drug-related Associated Review & Approval and Supervision
2019-07-16
NMPA issued the Announcement on Issues Concerning the Further Improvement of Drug-related Associated Review &Approval and Supervision.